Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.96
$0.010.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.10% | 28.63% | 83.92% | 88.14% | 16.89% |
| Total Depreciation and Amortization | 32.41% | 39.90% | 31.39% | 52.43% | 15.11% |
| Total Amortization of Deferred Charges | -32.64% | -32.64% | -32.64% | -32.64% | 116.45% |
| Total Other Non-Cash Items | -57.05% | -42.92% | -8.03% | 77.82% | 193.36% |
| Change in Net Operating Assets | -26.00% | 129.33% | -6.65% | -153.25% | -89.55% |
| Cash from Operations | -24.36% | 56.96% | 52.70% | 23.44% | 42.30% |
| Capital Expenditure | -162.82% | -95.84% | -39.51% | -5.84% | 44.48% |
| Sale of Property, Plant, and Equipment | -16.61% | 12.88% | -1.01% | 8.86% | 173.52% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.56% | -72.10% | -392.94% | -457.74% | -3,847.46% |
| Cash from Investing | 63.95% | -85.04% | -148.11% | -121.88% | -220.78% |
| Total Debt Issued | 16.98% | 29.26% | -17.31% | -22.17% | -41.76% |
| Total Debt Repaid | -0.55% | -12.62% | 23.30% | 24.49% | 29.77% |
| Issuance of Common Stock | -5.91% | -8.24% | -5.87% | -5.87% | 245.22% |
| Repurchase of Common Stock | 7.69% | 9.21% | 12.30% | 12.65% | -184.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 11.25% | 36.49% | 7.87% | -28.56% | -6.67% |
| Other Financing Activities | -3.87% | -9.52% | -3.70% | -1.85% | 30.38% |
| Cash from Financing | 50.40% | 58.31% | 30.96% | 8.92% | -125.96% |
| Foreign Exchange rate Adjustments | -191.24% | -170.58% | 1,193.59% | 215.92% | 170.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,314.88% | 1,123.53% | 1,382.10% | 216.61% | -91.69% |